Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| VRX | Valeant Pharmaceuticals International, Inc. | 3.27% | 29.07 | 14.1% | $171.05m | |
| ICLR | ICON plc | 0.93% | 229.20 | 4.2% | $156.70m | |
| JAZZ | Jazz Pharmaceuticals Plc | 0.57% | 179.17 | 2.2% | $142.15m | |
| HZNP | Horizon Therapeutics Plc | 5.02% | 92.14 | 5.5% | $124.53m | |
| CTLT | Catalent, Inc. | 2.18% | 102.67 | 2.1% | $105.63m | |
| BHC | Bausch Health Cos., Inc. | 3.27% | 29.07 | 0.0% | $91.68m | |
| SAVA | Cassava Sciences, Inc. | 8.31% | 40.92 | 0.0% | $55.78m | |
| UTHR | United Therapeutics Corp. | 2.12% | 197.87 | 14.0% | $55.65m | |
| PRGO | Perrigo Co. Plc | 1.80% | 45.82 | 6.9% | $49.71m | |
| BLRX | BioLineRx Ltd. | 0.00% | 2.85 | 0.8% | $38.97m | |
| ARGX | argenx SE | 4.22% | 272.30 | 0.0% | $38.23m | |
| SAGE | SAGE Therapeutics, Inc. | 2.03% | 70.86 | 7.6% | $33.60m | |
| PCRX | Pacira Biosciences, Inc. | 1.22% | 62.21 | 9.9% | $30.64m | |
| AXSM | Axsome Therapeutics, Inc. | -2.68% | 58.42 | 1.9% | $26.79m | |
| RVMD | Revolution Medicines, Inc. | 4.07% | 31.99 | 0.0% | $23.38m |
Company Profile
Intercept Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the research, development and commercialization of novel therapeutics in treating chronic liver diseases. Its product pipeline includes OCALIVA which is used for the treatment of biliary cholangitis, nonalcoholic steatohepatitis, sclerosing cholangitis and biliary atresia. The company was founded by Mark E. Pruzanski and Roberto Pellicciari on September 4, 2002 and is headquartered in New York, NY.